#east india pharmaceutical

[deevayrattan]

Financial results of FY22 East India Pharmaceutical Unlisted shares

Buy/sell East India Pharmaceutical Unlisted shares. Get to know the financial result of FY22. This past performance can give you the idea of current investment opportunity.

[johnthejacobs]

East India Pharmaceuticals Share Price on an Upward Trajectory

Introduction East India Pharmaceutical Work Limited, a prominent player in the pharmaceutical industry, has recently witnessed a significant rise in East India Pharmaceutical Share Price. This positive trend reflects the company's robust financial health, strategic advancements, and strong market positioning. East India Pharmaceutical Work Limited is engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical products, including generic drugs, branded formulations, and over-the-counter (OTC) medicines. The company has expertise in various therapeutic areas such as anti-infectives, analgesics, anti-diabetics, respiratory, cardiovascular, gastrointestinal, vitamins and minerals, dermaceuticals, and nutritional supplements.

With 85 years of excellence, East India Pharmaceutical Works has been committed to envisioning and defining scientific solutions, thereby introducing a range of revolutionary quality pharmaceutical products that address the evolving needs of the healthcare industry. The company is actively expanding its international presence and exploring new market opportunities, exporting medicines to over 50 countries across Asia, Africa, Europe, Latin America, and North America.

East India Pharmaceutical Works has developed several first-of-its-kind generic drugs in India, including the first indigenously developed antimalarial drug, the first generic version of metformin (an anti-diabetic), and the first generic version of ramipril (an anti-hypertensive). The company also boasts a strong pipeline of new products in development across various therapeutic areas.

Leveraging consumer insights and continuous advancements through advanced research, the company offers over 100 medical products under brands such as Enteroquinol, Vitazyme, Locula, Bactiv, Tonoferon, and Pyrigesic, catering to a wide range of healthcare needs.

East India Pharmaceutical Works Limited was incorporated on April 27, 1936, and its registered office is located at 6, Nandalal Bose Sarani, Kolkata, WB 700071, India.

Recent Share Price Performance In the past few months, East India Pharmaceuticals has seen its share price climb steadily. Market data indicates a notable increase of 15% over the last quarter, driven by various favorable factors. This upward trajectory has garnered attention from both retail and institutional investors.

Strong Financial Results One of the primary drivers behind the share price surge is the company's impressive financial performance. East India Pharmaceuticals reported higher-than-expected revenue and profit margins in its latest quarterly results. The company's diverse product portfolio, including generic drugs, branded formulations, and OTC medicines, has contributed to this financial success.

Strategic Developments The company has made significant strategic advancements, further bolstering investor confidence. Recent investments in research and development, along with successful product launches in key therapeutic areas such as anti-infectives, analgesics, and anti-diabetics, have positioned East India Pharmaceuticals for sustained growth. Additionally, the company’s expansion into new markets has opened up fresh revenue streams.

Positive Market Sentiment The market sentiment surrounding East India Pharmaceuticals has been overwhelmingly positive. Analysts have highlighted the company's strong fundamentals and growth potential, leading to several upgrades in stock ratings. This positive outlook has been a crucial factor in driving up the share price.

Expert Opinions Financial analysts and industry experts have commended East India Pharmaceuticals for its strategic vision and operational excellence. Many experts believe that the company is well-equipped to navigate the competitive pharmaceutical landscape, citing its robust pipeline of new products and ongoing expansion efforts.

Investor Interest The rising share price has attracted a significant amount of investor interest. Increased trading volumes and heightened activity in the company’s shares indicate strong market confidence. Many investors are optimistic about the company’s future prospects and are keen to capitalize on its growth trajectory.

Future Outlook Looking ahead, the future appears promising for East India Pharmaceuticals. The company’s commitment to innovation, strategic market expansions, and strong financial performance are expected to drive continued growth. Analysts predict that the share price could see further gains as the company continues to execute its business strategies effectively.

Conclusion The upward trajectory of East India Pharmaceuticals' share price highlights the company’s solid performance and positive market perception. With strong financial results, strategic developments, and favorable market sentiment, East India Pharmaceuticals is poised for sustained success, making it an attractive investment opportunity in the pharmaceutical sector.

[transmutationisms]

in addition to being prone to an obvious naturalistic fallacy, the oft-repeated claim that various supplements / herbs / botanicals are being somehow suppressed by pharmaceutical interests seeking to protect their own profits ('they would rather sell you a pill') belies a clear misunderstanding of the relationship between 'industrial' pharmacology and plant matter. bioprospecting, the search for plants and molecular components of plants that can be developed into commercial products, has been one of the economic motivations and rationalisations for european colonialism and imperialism since the so-called 'age of exploration'. state-funded bioprospectors specifically sought 'exotic' plants that could be imported to europe and sold as food or materia medica—often both, as in the cases of coffee or chocolate—or, even better, cultivated in 'economic' botanical gardens attached to universities, medical schools, or royal palaces and scientific institutions.

this fundamental attitude toward the knowledge systems and medical practices of colonised people—the position, characterising eg much 'ethnobotany', that such knowledge is a resource for imperialist powers and pharmaceutical manufacturers to mine and profit from—is not some kind of bygone historical relic. for example, since the 1880s companies including pfizer, bristol-myers squibb, and unilever have sought to create pharmaceuticals from african medicinal plants, such as strophanthus, cryptolepis, and grains of paradise. in india, state-created databases of valuable 'traditional' medicines have appeared partly in response to a revival of bioprospecting since the 1980s, in an increasingly bureaucratised form characterised by profit-sharing agreements between scientists and local communities that has nonetheless been referred to as "biocapitalism". a 1990 paper published in the proceedings of the novartis foundation symposium (then the ciba foundation symposium) spelled out this form of epistemic colonialism quite bluntly:

Ethnobotany, ethnomedicine, folk medicine and traditional medicine can provide information that is useful as a 'pre-screen' to select plants for experimental pharmacological studies.

there is no inherent oppositional relationship between pharmaceutical industry and 'natural' or plant-based cures. there are of course plenty of examples of bioprospecting that failed to translate into consumer markets: ginseng, introduced to europe in the 17th century through the mercantile system and the east india company, found only limited success in european pharmacology. and there are cases in which knowledge with potential market value has actually been suppressed for other reasons: the peacock flower, used as an abortifacient in the west indies, was 'discovered' by colonial bioprospectors in the 18th century; the plant itself moved easily to europe, but knowledge of its use in reproductive medicine became the subject of a "culturally cultivated ignorance," resulting from a combination of funding priorities, national policies, colonial trade patterns, gender politics, and the functioning of scientific institutions. this form of knowledge suppression was never the result of a conflict wherein bioprospectors or pharmacists viewed the peacock flower as a threat to their own profits; on the contrary, they essentially sacrificed potential financial benefits as a result of the political and social factors that made abortifacient knowledge 'unknowable' in certain state and commercial contexts.

exploitation of plant matter in pharmacology is not a frictionless or infallible process. but the sort of conspiratorial thinking that attempts to position plant therapeutics and 'big pharma' as oppositional or competitive forces is an ahistorical and opportunistic example of appealing to nominally anti-capitalist rhetoric without any deeper understanding of the actual mechanisms of capitalism and colonialism at play. this is of course true whether or not the person making such claims has any personal financial stake in them, though it is of course also true that, often, they do hold such stakes.

[weirdly-specific-but-ok]

WebMD Page for Aziraphale

As promised to you all, inspired by that video of Aziraphale as an antidepressant. The WebMD drug format, from your clearly deranged mascot, Asmi. This took way too much effort. For legal purposes, even though this blog is a lawless hellscape, this is a spoof. If you did like it, reblog it, maggoty loves of mine, because likes don't help visibility on tumblr, and I want everyone to be traumatised with my own specific brand of unhinged. No pressure though, be rebels muaha. That being said:

MENU > DRUGS & MEDICATIONS > AZIRAPHALE

COMMON BRAND(S): Guardian of the East Gate, Angel GENERIC NAME(S): Aziraphale

USES This medication is used to treat mood-related disorders ranging from depression to chronic loneliness and anxiety. It has also been proven effective in treatment of Compulsive Demonic Behavioural Disorder (CDBD) and Post Fall Stress Disorder (PFSD). The medication results in an overall improvement in mood (see Side Effects), morals, and lifestyle choices. This medication is sometimes described as a 'miracle-worker'. It is advisable to ensure that the correct dosage is taken at regular intervals. The doctor/God/Forces That Be may prescribe a lower dose at the start, gradually increasing frequency and amount over the course of millennia.

SIDE EFFECTS Documented side-effects include pining behaviour, severe withdrawal symptoms in case of suddenly stopping the medication, heart palpitations, stuttering or stammering, mood swings including irrational lashing out or defensive behaviour when faced with highly emotional situations, break-ups, misunderstands, obliviousness, amongst others. Despite the studies being limited to a single subject (see Crowley et. al. updated 2023) these effects are typically harmless in the long term. Life-altering effects may also be noted, including irretrievably falling in love, marriage, a positive character arc, tendencies to put oneself at risk to ensure continuation of medication, lifelong friendship, fate-defying romance and severe allergy to the idea of discontinuation of medication.

WARNINGS Casual or reckless consumption can be too fast for the medication, which will lessen its effects, leading to withdrawal symptoms. Withdrawal symptoms range from repeated indulging in CDBD and PFSD induced behaviours to alcoholism, depressive episodes, recklessness, listlessness, and prolonged car rides with no purpose. While the medication should not be consumed too fast, regularity is also advised. This is a long-term medication and not a short-term fix. Rare, short-term exposures will only worsen the side effects, withdrawal symptoms and may even reverse the drug effects.

PRECAUTIONS Ensure immortality so that the medication may be able to work its effect through the full course. Pre-existing trauma and heart conditions may require regular consultations with a therapist.

INTERACTIONS Drug interactions may change how the medication works or increase severity of side effects. This document does not include a comprehensive list of all drug interactions, please do adequate research and check instructions on the medication before proceeding with additional drugs. Aziraphale is known to have highly negative interactions with the toxin hellfire as well as the drugs Gabriel (only when sold as Supreme Archangel), Satan and Metatron (known toxin). Negative interference may occur due to most drugs from the class Heaven and Hell. Vague interference may occur with the drug class Homo sapiens.

OVERDOSE While less dangerous than withdrawal symptoms, overdose may lead to lack of personal space, miscommunication, and decrease in mood stability. Increased irritability is also common. Use with caution.

IMAGE

REVIEWS (1) Effectiveness: 5 stars Ease of use: 4 stars Satisfaction: 100000000000000000000e stars

It must be noted that in the country where I live (India), advertisements for pharmaceutical drugs are legally prohibited on television and other media. Which is why I was very bewildered at the initial video. But WebMD is a universal phenomenon so this shall by my contribution to the fandom. Thank you @neil-gaiman, Good Omens has given me a lot of opportunities to exercise my brain in all the weirdest ways.

[fatehbaz]

Because most medicines were produced from [...] plants [...] these early “pharmaceutical monopolies” required full control of the production and trade of a species. Russia successfully managed the rhubarb trade in the seventeenth and eighteenth centuries, while Spain controlled the distribution [...] from Spanish America, mainly cinchona from Peru, in the same period. “True” cinnamon grew only on Sri Lanka, so whoever controlled the island could dominate the cinnamon trade. The Portuguese were the first to create a monopoly on the cinnamon trade there in the early seventeenth century. That monopoly was later optimized by the Dutch in the late eighteenth century [...].

“True” should indeed be in quotation marks here - the term reflects the historically contingent tastes of Europeans, rather than any botanical category [...]. The rarity of cinnamon in the early modern period made it one of the most coveted spices of that era, and European countries without direct access to the cinnamon trade tried to imitate, substitute, steal, smuggle, or transplant the “true” product from Sri Lanka. [...]

---

In the early modern period, cinnamon was also important both as an exotic commodity and as an important therapeutic substance. The Dutch East India Company (VOC), which controlled Sri Lanka between 1658 and 1796, was well aware of this. The VOC vigorously exploited the Salagama - [...] specialized Sri Lankan cinnamon peelers - to supply enough cinnamon, which for a long time was gathered from forests. Only after the peelers rebelled, leading to a war that lasted between 1760 and 1766, did the company revise its production policy. 

Experiments with “cinnamon gardens” (kaneeltuinen in Dutch) led to enormous successes, and the company eventually grew millions of cinnamon trees on plantations in the final decades of the eighteenth century. Meanwhile, competitors of the Dutch had come up with their own solutions [...]: Spain had started growing other Cinnamomum species on plantations in the Philippines, while France and Britain succeeded in transplanting cinnamon to islands in the Caribbean. But the Dutch monopoly was not simply threatened by outside competition. Smuggling, by peelers or VOC personnel, was strictly forbidden and severely punished. [...]

---

Hendrik Adriaan van Rheede tot Drakenstein (1636–1691) was the VOC administrator on India’s Malabar Coast when he started experimenting with cinnamon oil in the 1670s.

He concluded that the oil, which he extracted from the roots of local cinnamon trees, was of better quality than oil from cinnamon trees on Sri Lanka. Van Rheede reported these results in his entry on cinnamon in volume 1 of the Hortus Indicus Malabaricus, the twelve-volume book that was produced by a team of local and European scholars, and supervised by Van Rheede himself.

Van Rheede’s assessment of cinnamon - in fact, the very publication of a multi-volume work about the flora of Malabar - infuriated the governor of Sri Lanka, Rijckloff van Goens, who had secured the cinnamon monopoly of Sri Lanka for the Dutch. Van Goens insisted that Van Rheede stop his medical experiments, claiming that the monopoly was at risk if the cinnamon trade was extended beyond the island of Sri Lanka. 

But Van Goens was not so much concerned about the therapeutic efficacy of cinnamon from either of the two regions. He was motivated by an imperial agenda and regarded the natural products of Sri Lanka as superior to anything similar in the region.

The experiments of Van Rheede, who was his former protégé, threatened not so much the botanical quality of the product, or the commercial interests of the Dutch East India Company, but rather the central position of Sri Lanka in the Dutch colonial system and the position of Van Goens as the representative of that system.

---

Even when Sri Lanka still only produced cinnamon that grew in the wild, the Dutch harvested enough to supply an international market and were able to dictate the availability and price level throughout the world. The monopoly, whether defined in commercial or pharmaceutical terms, was not easily put at risk by efforts like Van Rheede’s. Those involved in the early modern cinnamon trade were motivated by various reasons to defend or undermine the central position of Sri Lankan cinnamon: botanical, medical, commercial, or imperial. These motives often overlapped.

---

All text above by: Wouter Klein. “Plant of the Month: Cinnamon.” JSTOR Daily. 17 February 2021. “Plant of the Month” series is part of the Plant Humanities Initiative, a partnership of Dumbarton Oaks and JSTOR Labs. [Bold emphasis and some paragraph breaks/contractions added by me. Presented here for commentary, teaching, criticism purposes.]

[rupalic]

Growth Strategies Adopted by Major Players in Turf Protection Market

In the dynamic landscape of the turf protection industry, key players like Syngenta Crop Protection AG (Switzerland), UPL Limited (India), Corteva Agriscience (US), Nufarm (US), Bayer AG (Germany), and BASF SE (Germany) are at the forefront of innovation and market expansion. These industry leaders are driving growth through strategic initiatives such as partnerships, acquisitions, and cutting-edge product developments, solidifying their positions as influential forces in shaping the future of the turf protection industry. Their efforts not only enhance their global presence but also set new benchmarks for industry standards and customer expectations. The global turf protection market size is estimated to reach $8.1 billion by 2028, growing at a 4.9% compound annual growth rate (CAGR). The market size was valued $6.4 billion in 2023.

Top Global Turf Protection Leaders to Watch in 2024

· Syngenta Crop Protection AG (Switzerland)

· UPL Limited (India)

· Corteva Agriscience (US)

· Nufarm (US)

· Bayer AG (Germany)

· BASF SE (Germany)

· SDS Biotech K.K. (Japan)

· AMVAC Chemical Corporation (US)

· Bioceres Crop Solutions (Argentina)

· Colin Campbell (Chemicals) Pty Ltd (Australia)

· ICL Group Ltd. (US)

Investments and Innovations: Key Strategies of Top Turf Protection Companies

🌱 Syngenta Crop Protection AG: Leading the Way in Integrated Pest Management

Syngenta Crop Protection AG, a global agribusiness based in Switzerland, operates prominently in the crop protection and seeds markets. The company offers a comprehensive range of herbicides, insecticides, fungicides, and seed treatments, helping growers worldwide enhance agricultural productivity and food quality. With a presence in over 90 countries, Syngenta’s reach is truly global. In October 2020, Syngenta further strengthened its position by acquiring Valagro, a leading biologicals company. Valagro’s strong presence in Europe, North America, Asia, and Latin America complements Syngenta’s existing crop protection chemicals. This acquisition allows Syngenta to offer more integrated pest management strategies that reduce reliance on synthetic chemicals, while Valagro’s expertise in plant nutrition promotes healthier turfgrass growth and improved soil health.

Know about the assumptions considered for the study

🌍 UPL Limited: Innovating Turf Management Solutions Globally

UPL Limited, formerly known as United Phosphorus Limited, is a global agrochemical company based in India, providing a wide range of agricultural solutions, including crop protection products, seeds, and post-harvest solutions. UPL is a key player in turf management, offering innovative solutions for golf courses, sports fields, and other turf areas. Their product portfolio includes herbicides, fungicides, insecticides, and plant growth regulators, all designed to enhance turf quality and health while effectively controlling pests and diseases. Operating in over 130 countries across North America, South America, Europe, and Asia Pacific, UPL has 28 manufacturing sites worldwide, solidifying its position as a leader in the global turf protection market.

🏆 Bayer AG: Streamlining for a Focused Future in Turf Protection

Bayer AG, a multinational pharmaceutical and life sciences company headquartered in Leverkusen, Germany, operates across three business segments: Pharmaceuticals, Consumer Health, and Crop Science. The company’s Crop Science division caters to the turf protection market, offering products such as herbicides, insecticides, and fungicides. With operations in over 90 countries, including regions like North America, South America, Europe, the Middle East, Africa, and Asia Pacific, Bayer maintains a strong global presence. In March 2022, Bayer sold its Environmental Science Professional business, which includes turf protection products, to private equity firm Cinven for USD 2.6 billion. This strategic divestment is part of Bayer’s ongoing efforts to streamline its portfolio and concentrate on core businesses, ensuring a more focused approach to its future operations.

[justinspoliticalcorner]

Lori Ann Larocco at CNBC:

Billions in trade came to a screeching halt at U.S. East Coast and Gulf Coast ports after members of the International Longshoremen’s Association (ILA) began walking off the job after 12:01 a.m. ET on October 1. The ILA is North America’s largest longshoremen’s union, with roughly 50,000 of its 85,000 members making good on the threat to strike at 14 major ports subject to a just-expired master contract with the United States Maritime Alliance (USMX), and picketing workers beginning to appear at ports. The union and port ownership group failed to reach agreement by midnight on a new contract in a protracted battle over wage increases and use of automation. In a last-ditch effort on Monday to avert a strike that will cause significant harm to the U.S. economy if it is lengthy — at least hundreds of millions of dollars a day at the largest ports like New York/New Jersey — the USMX offered a nearly 50% wage hike over six years, but that was rejected by the ILA, according to a source close to the negotiations. The port ownership group said it hoped the offer would lead to a resumption of collective bargaining.

The 14 ports where preparations for a strike have been underway are Boston, New York/New Jersey, Philadelphia, Wilmington, North Carolina, Baltimore, Norfolk, Charleston, Savannah, Jacksonville, Tampa, Miami, New Orleans, Mobile, and Houston. New York Governor Kathy Hochul said in a statement issued shortly after midnight that “the first large-scale eastern dockworker strike in 47 years began at ports from Maine to Texas, including at the Port Authority of New York and New Jersey. In preparation for this moment, New York has been working around the clock to ensure that our grocery stores and medical facilities have the essential products they need.” Rhetoric from ILA leadership has been aggressive in the weeks leading up to the strike, with ILA president Harold Daggett, who was a union member the last time it went out on strike in 1977, telling rank-and-file members — who unanimously voted to authorize a strike — in a recent video message, “We’ll crush them.” 

[...] The most significant issues would be faced by food and automobile industries, Kamins said, as they rely especially heavily on the ports that will be shut down. While a surge in inflation is highly unlikely even with a longer strike, even a modest reacceleration could create uncertainty and force the Federal Reserve to be more cautious about lowering interest rates, which would weigh on the overall outlook for job growth and investment. A one-week strike could cost the U.S. economy $3.78 billion, according to an analysis by The Conference Board, and cause supply chain slowdowns through mid-November. In all, the ports threatened with strikes handle $3 trillion annually in U.S. annual international trade.

Many industries are preparing for major repercussions. Noushin Shamsili, CEO and president of Nuco Logistics, which specializes in pharmaceutical imports and exports, said the strike comes at a critical time for inventory replenishment for the pharma sector. “Almost all of this industry is just on time,” said Shamsili. “Raw materials are being brought in to complete drug manufacturing. Medical supplies for clinics and hospitals are on these vessels. For a while importers did not bring in a lot of cargo because they were overflowing with supplies post-Covid. Now they have started reordering medical devices, gloves, syringes, and tubing.” Shamsili also said the East Coast ports are a gateway for generic medicine made in India. Approximately 48% of the active pharmaceutical ingredients used in the U.S. are being imported from India. Without these APIs, medications cannot be produced. APIs are also manufactured in Europe, which also use the East Coast ports as U.S. points of entry.

[...] The Biden administration finds itself in a delicate political moment, with the presidential election one month away and President Biden vowing he will not use existing labor law to force union workers back on the job, which is within his powers under the Taft-Hartley Act. The Taft-Hartley Act, passed in 1947, was a revision of U.S. law governing labor relations and union activity that granted a U.S. president the power to suspend a strike for an 80-day “cooling off period” in cases where “national health or safety” are at risk. 

Today begins the strike along East Coast and Gulf Coast ports after International Longshoremen’s Association (ILA) members walked off their jobs.

This strike, depending on how long it lasts, could have a major impact on the elections and the economy.

[trendingreportz]

Acetic Acid Market - Forecast(2024 - 2030)

Acetic Acid Market Overview

Acetic Acid Market Size is forecast to reach $14978.6 Million by 2030, at a CAGR of 6.50% during forecast period 2024-2030. Acetic acid, also known as ethanoic acid, is a colorless organic liquid with a pungent odor. The functional group of acetic acid is methyl and it is the second simplest carboxylic acid. It is utilized as a chemical reagent in the production of many chemical compounds. The major use of acetic acid is in the manufacturing of vinyl acetate monomer, acetic anhydride, easter and vinegar. It is a significant industrial chemical and chemical reagent used in the production of photographic film, fabrics and synthetic fibers. According to the Ministry of Industry and Information Technology, from January to September 2021, the combined operating revenue of 12,557 major Chinese garment companies was US$163.9 billion, showing a 9% increase. Thus, the growth of the textile industry is propelling the market growth for Acetic Acid.

Report Coverage

The “Acetic Acid Market Report – Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Acetic Acid industry.

By Form: Liquid and Solid.

By Grade: Food grade, Industrial grade, pharmaceutical grade and Others.

By Application: Vinyl Acetate Monomer, Purified Terephthalic Acid, Ethyl Acetate, Acetic Anhydride, Cellulose Acetate, Acetic Esters, Dyes, Vinegar, Photochemical and Others 

By End-use Industry: Textile, Medical and Pharmaceutical, Oil and Gas, Food and Beverages, Agriculture, Household Cleaning Products, Plastics, Paints & Coating and Others.

By Geography: North America (the USA, Canada and Mexico), Europe (the UK, Germany, France, Italy, Netherlands, Spain, Russia, Belgium and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia and New Zealand, Indonesia, Taiwan, Malaysia and the Rest of APAC), South America (Brazil, Argentina, Colombia, Chile and the Rest of South America) and the Rest of the World (the Middle East and Africa).

Request Sample

Key Takeaways

The notable use of Acetic Acid in the food and beverages segment is expected to provide a significant growth opportunity to increase the Acetic Acid Market size in the coming years. As per the US Food and Agriculture Organization, world meat production reached 337 million tonnes in 2019, up by 44% from 2000.

The notable demand for vinyl acetate monomer in a range of industries such as textile finishes, plastics, paints and adhesives is driving the growth of the Acetic Acid Market. 

Increase in demand for vinegar in the food industry is expected to provide substantial growth opportunities for the industry players in the near future in the Acetic Acid industry.

Acetic Acid Market Segment Analysis – by Application

The vinyl acetate monomer segment held a massive 44% share of the Acetic Acid Market share in 2021. Acetic acid is an important carboxylic acid and is utilized in the preparation of metal acetates and printing processes, industrially. For industrial purposes, acetic acid is manufactured by air oxidation of acetaldehyde with the oxidation of ethanol, butane and butene. Acetic acid is extensively used to produce vinyl acetate which is further used in formulating polyvinyl acetate. Polyvinyl acetate is employed in the manufacturing of plastics, paints, textile finishes and adhesives. Thus, several benefits associated with the use of vinyl acetate monomer is boosting the growth and is expected to account for a significant share of the Acetic Acid Market.

Inquiry Before Buying

Acetic Acid Market Segment Analysis – by End-use Industry

The food and beverages segment is expected to grow at the fastest CAGR of 7.5% during the forecast period in the Acetic Acid Market. Acetic Acid is also known as ethanoic acid and is most extensively used in the production of vinyl acetate monomer. Vinyl acetate is largely used in the production of cellulose acetate which is further used in several industrial usage such as textiles, photographic films, solvents for resins, paints and organic esters. PET bottles are manufactured using acetic acid and are further utilized as food containers and beverage bottles. In food processing plants, acetic acid is largely used as cleaning and disinfecting products. Acetic acid is extensively used in producing vinegar which is widely used as a food additive in condiments and the pickling of vegetables. According to National Restaurant Association, the foodservice industry is forecasted to reach US$898 billion by 2022. Thus, the advances in the food and beverages industry are boosting the growth of the Acetic Acid Market. 

Acetic Acid Market Segment Analysis – by Geography

Asia-Pacific held a massive 41% share of the Acetic Acid Market in 2021. This growth is mainly attributed to the presence of numerous end-use industries such as textile, food and beverages, agriculture, household cleaning products, plastics and paints & coatings. Growth in urbanization and an increase in disposable income in this region have further boosted the industrial growth in this region. Acetic acid is extensively used in the production of metal acetates, vinyl acetate and vinegar which are further utilized in several end-use industries. Also, Asia-Pacific is one of the major regions in the domain of plastic production which provides substantial growth opportunities for the companies in the region. According to Plastic Europe, China accounted for 32% of the world's plastic production. Thus, the significant growth in several end-use industries in this region is also boosting the growth of the Acetic Acid Market.

Acetic Acid Market Drivers 

Growth in the textile industry:

Acetic Acid, also known as ethanoic acid, is widely used in the production of metal acetate and vinyl acetate which are further used in the production of chemical reagents in textiles, photographic films, paints and volatile organic esters. In the textile industry, acetic acid is widely used in textile printing and dyes. According to China’s Ministry of Industry and Information Technology, in 2020, textile and garment exports from China increased by 9.6% to US$291.22 billion. Also, according to the U.S. Department of Commerce, from January to September 2021, apparel exports increased by 28.94% to US$4.385 billion, while textile mill products rose by 17.31% to US$12.365 billion. Vinyl acetate monomer is utilized in the textile industry to produce synthetic fibers. Thus, the global growth in demand for textiles is propelling the growth and is expected to account for a significant share of the Acetic Acid Market size.

Schedule a call

Surge in use of vinegar in the food industry:

The rapid surge in population along with the adoption of a healthy and sustainable diet has resulted in an increase in demand for food items, thereby increasing the global production level of food items. As per US Food and Agriculture Organization, in 2019, global fruit production went up to 883 million tonnes, showing an increase of 54% from 2000, while global vegetable production was 1128 million tonnes, showing an increase of 65%. Furthermore, world meat production reached 337 million tonnes in 2019, showing an increase of 44% from 2000. Acetic acid is majorly used in the preparation of vinegar which is further widely utilized as a food ingredient and in personal care products. Vinegar is used in pickling liquids, marinades and salad dressings. It also helps to reduce salmonella contamination in meat and poultry products. Furthermore, acetic acid and its sodium salts are used as a food preservative. Thus, the surge in the use of vinegar in the food industry is boosting the growth of the Acetic Acid Market.

Acetic Acid Market Challenge

Adverse impact of acetic acid on human health:

Acetic Acid is considered a strong irritant to the eye, skin and mucous membrane. Prolong exposure to and inhalation of acetic acid may cause irritation to the nose, eyes and throat and can also damage the lungs. The workers who are exposed to acetic acid for more than two or three years have witnessed upper respiratory tract irritation, conjunctival irritation and hyperkeratotic dermatitis. The Occupational Safety and Health Administration (OSHA) reveals that the standard exposure to airborne acetic acid is eight hours. Furthermore, a common product of acetic acid i.e., vinegar can cause gastrointestinal tract inflammatory conditions such as indigestion on excess consumption. Thus, the adverse impact of Acetic Acid may hamper the market growth. 

Buy Now

Acetic Acid Industry Outlook

The top 10 companies in the Acetic Acid Market are:

Celanese Corporation

Eastman Chemical Company

LyondellBasell

British Petroleum

Helm AG

Pentoky Organy

Dow Chemicals

Indian Oil Corporation

Daicel Corporation

Jiangsu Sopo (Group) Co. Ltd.

Recent Developments

In March 2021, Celanese Corporation announced the investment to expand the production facility of vinyl portfolio for the company’s acetyl chain and derivatives in Europe and Asia.

In April 2020, Celanese Corporation delayed the construction of its new acetic acid plant and expansion of its methanol production by 18 months at the Clear Lake site in Texas.

In October 2019, BP and Chian’s Zhejiang Petroleum and Chemical Corporation signed MOU in order to create a joint venture to build a 1 million tonne per annum Acetic Acid plant in eastern China.

Key Market Players:

The Top 5 companies in the Acetic Acid Market are:

Celanese Corporation

Ineos Group Limited

Eastman Chemical Company

LyondellBasell Industries N.V.

Helm AG

For more Chemicals and Materials Market reports, please click here

[harshnews]

IBC Cap Market Size, Share, Trends, Growth and Competitive Analysis

"IBC Cap Market – Industry Trends and Forecast to 2028

Global IBC Cap Market, By Product Type (Flange, Plugs, Vent-in Plug, Vent-out Plug and Screw closure), Type (Plastic IBC, Metal IBC and Composite IBCs), Material Type (Plastics, Metal, Aluminium and Steel), End Use (Chemicals & Fertilizers, Petroleum & Lubricants, Paints, Inks & Dyes, Food & Beverage, Agriculture, Building & Construction, Healthcare & Pharmaceuticals and Mining), Application (Food And Drinks, Chemical Industry, Oil and Agriculture), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Access Full 350 Pages PDF Report @

The global IBC cap market is expected to witness significant growth over the forecast period due to the increasing demand for intermediate bulk containers (IBCs) in various industries such as chemicals, food and beverages, pharmaceuticals, and others. The IBC caps play a crucial role in ensuring the safe storage and transportation of liquid products. The market growth is also being driven by technological advancements in IBC cap designs, such as tamper-evident seals and spouts for easy dispensing. Additionally, the growing focus on sustainability and recyclability of packaging materials is further boosting the adoption of IBC caps made from eco-friendly materials.

**Segments**

- Based on material type, the IBC cap market can be segmented into plastic, metal, and others. Plastic caps are widely used due to their lightweight nature and cost-effectiveness. - By cap type, the market can be categorized into screw caps, snap-on caps, and flip-top caps. Screw caps are preferred for their secure sealing properties. - On the basis of end-user industry, the market can be divided into chemicals, food and beverages, pharmaceuticals, and others. The chemicals segment is anticipated to hold a significant market share due to the widespread use of IBCs for storing chemical products.

**Market Players**

- TPS Industrial Srl - Schuetz GmbH & Co. KGaA - Mauser Packaging Solutions - Time Technoplast Ltd - Berry Global Inc. - THIELMANN UCON AG - Precision IBC, Inc. - Peninsula Packaging LLC

These market players are actively involved in strategic initiatives such as product launches, partnerships, and acquisitions to strengthen their market presence and expand their product offerings. The competitive landscape of the IBC cap market is characterized by intense competition, prompting companies to focus on innovation and quality to gain a competitive edge.

The Asia-Pacific region is expected to witness substantial growth in the IBC cap market, driven by the rapid industrialization and the increasing adoption of IBCsThe Asia-Pacific region represents a significant growth opportunity for the global IBC cap market due to several key factors. With rapid industrialization and the expanding manufacturing sector in countries like China, India, and Southeast Asia, there is a growing demand for efficient storage and transportation solutions, including IBCs and their associated caps. The increased focus on chemical production, food processing, and pharmaceutical manufacturing in the region further fuels the need for reliable packaging solutions like IBC caps. As these industries continue to grow, the adoption of IBC caps is expected to rise, driving market expansion in the Asia-Pacific region.

Moreover, the emphasis on enhancing safety standards and ensuring product integrity is a crucial factor contributing to the growth of the IBC cap market in Asia-Pacific. Regulations regarding the safe handling and transportation of hazardous chemicals and pharmaceuticals necessitate the use of high-quality caps that can effectively seal and protect the contents of IBCs. As companies in the region strive to comply with stringent regulatory requirements, the demand for advanced and secure IBC caps is projected to increase significantly.

Additionally, the shift towards sustainability and eco-friendly practices is another trend shaping the IBC cap market in Asia-Pacific. With growing environmental concerns and increasing awareness about plastic pollution, there is a rising preference for IBC caps made from recyclable and biodegradable materials. Market players in the region are focusing on developing sustainable packaging solutions to meet the evolving consumer demands and align with global sustainability goals. This shift towards eco-friendly IBC caps not only addresses environmental concerns but also presents market players with opportunities to differentiate their offerings and attract environmentally conscious customers.

Furthermore, the competitive landscape of the IBC cap market in Asia-Pacific is characterized by the presence of both local manufacturers and international players. Local companies often have a strong understanding of regional market dynamics and customer preferences, giving them a competitive advantage in catering to specific industry needs. On the other hand, multinational companies bring technological expertise and a wide product portfolio, which can appeal to a broader customer base seeking innovative and**Global IBC Cap Market, By Product Type**

- Flange - Plugs - Vent-in Plug - Vent-out Plug - Screw closure

**Type**

- Plastic IBC - Metal IBC - Composite IBCs

**Material Type**

- Plastics - Metal - Aluminium - Steel

**End Use**

- Chemicals & Fertilizers - Petroleum & Lubricants - Paints, Inks & Dyes - Food & Beverage - Agriculture - Building & Construction - Healthcare & Pharmaceuticals - Mining

**Application**

- Food And Drinks - Chemical Industry - Oil and Agriculture

The Global IBC Cap market is experiencing significant growth due to the rising demand for intermediate bulk containers across various industries. Plastic caps are increasingly preferred for their lightweight and cost-effective nature, driving market growth within the material type segment. Screw caps, known for their secure sealing properties, dominate the cap type category. The chemicals segment is anticipated to hold a substantial market share among end-user industries, attributed to the widespread use of IBCs for chemical storage. The market players in the industry are focusing on strategic initiatives like product launches and partnerships to enhance their market presence and offerings. The competitive landscape is intense, spurring companies to innovate and prioritize quality for a competitive advantage.

In Asia-Pacific, the IBC cap market is poised for robust growth fueled by rapid industrialization and the expanding manufacturing sector, particularly in countries like China,

Countries Studied:

North America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Key Coverage in the IBC Cap Market Report:

Detailed analysis of IBC Cap Market by a thorough assessment of the technology, product type, application, and other key segments of the report

Qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period

Investigative study of the market dynamics including drivers, opportunities, restraints, and limitations that can influence the market growth

Comprehensive analysis of the regions of the IBC Cap industry and their futuristic growth outlook

Competitive landscape benchmarking with key coverage of company profiles, product portfolio, and business expansion strategies

TABLE OF CONTENTS

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers and Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse Trending Reports:

Calcium Glycinate Market Retinal Biologics Market Facial Fat Transfer Market Angio Suites Diagnostic Imaging Market Adoption Of Benelux Power Tools Market De Quervains Tenosynovitis Treatment Market Biodetectors And Accessories Market Colposcope Market Sports Medicine Market Automotive Adhesives Market Infrared Imaging Market Vapour Deposition Market Professional Diagnostics Market Ct Scanner Market Programmable Application Specific Integrated Circuit Asic Market Hospital Operating Room Or Products And Solutions Market Castor Oil Market Zika Virus Infection Drug Market Toluene Diisocynate Market Antibiotic Resistance Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[deevayrattan]

A Deep Dive into Performance and financials of Unlisted Companies

Check Financials of carrier air conditioner, East India Pharmaceutical IPO, philips domestic appliances india & India Carbon

[foodandbeverages]

Organic Acid Market Potential Growth, Share, Demand And Analysis Of Key Players- Analysis Forecasts To 2032

In 2022, it is anticipated that the organic acids market will reach US$ 11.3 billion. The market for organic acid is expected to reach US$ 18.8 Bn by 2032, growing at a constant CAGR of 5.3% throughout the projected period.

Market prospects are anticipated to be favorable due to the expanding use of organic acids in the food and beverage industry. In addition, during the course of the projection period, there will be chances for market expansion due to the rising demand for organic acid alternatives.

These acids have multiple applications in animal feed industry to inhibit bacterial growth and provide hosts with nutritional content. They are used in cosmetics to get rid of dead cells and nourish skin. Owing to these factors, demand for organic acids is expected to rise in the forthcoming years.

To remain ‘ahead’ of your competitors, request for @ https://www.futuremarketinsights.com/reports/sample/rep-gb-159

Consumers are adopting a healthy lifestyle and are conscious about the intake of any products that contain chemical ingredients which be harsh on their skin or cause any side effects because of daily consumption.

Consumer preference for brands that are offering organic products without harmful chemical additives is expected to influence the demand for organic acids. To fulfil rising consumer demand for natural products, manufacturers are developing technologies and clean label products that do not cause any harm to environment and human health.

Asia Pacific is expected to witness surge in demand for organic acids due to less stringent policies. North America is expected to be the hub for manufacturing and export of different organic acids due to easy availability of infrastructure and technical know-how.

“Growing preference for clean label products across the food & beverage sector, coupled with increasing incorporation of organic acids in animal feed will steer growth in the market over the forecast period,” says an FMI analyst. 

Key Takeaways:

The     organic acid market is expected to grow at CAGR of 5.2% and 4.2% in North     America and the Latin America, respectively, through 2032.

Asia     Pacific is expected to account for 30% of the total organic acid market     share share.

The     Europe organic acid market is expected to reach a valuation of US$ 4.5 Bn     over the forecast period.

Total     sales in the U.S. organic acids market will reach a valuation of US$ 2.1     Bn in 2022.

The     India organic acid market valuation will total US$ 1.07 Bn in 2022.

By     application, sales in the poultry and farming segment are projected to     account for 30% of the total market share.

Based     on product type, demand for citric acid will continue gaining traction.

Competitive Landscape

Key organic acid manufacturers are focusing on research & development to offer various products with no chemical additives. Key players are collaborating and developing new products to penetrate untapped markets. For instance:

Eastman     Chemical Company announced the acquisition of 3F Feed & Food, a     European pioneer in the commercial and technical producer of livestock     feed and human food additives. 3F’s operations and assets, which are based     in Spain, will improve and support Eastman’s animal nutrition industry’s     sustained future demand and will be integrated into the company’s     Additives & Functional Products division.

Explore More Valuable Insights

Future Market Insights, in its new report, offers an impartial analysis of the global reduced fat butter market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.

The study offers compelling insights based on  Product Type (Lactic Acid, Formic Acid,  Acetic Acid, Citric Acid,  Propionic Acid, Ascorbic Acid, Gluconic Acid, Fumaric Acid), Application (Poultry and Farming, Pharmaceuticals, Industrial, Food & Beverages)Region (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA).

Frequently Asked Questions

How     much is the global organic acid market worth?

What     is the demand outlook forecast for the organic acid market?

At     what rate did the demand for organic acid grow between 2027 to 2021?

At     what rate will organic acid demand grow in Europe?

What     is the North America organic acid market outlook?

Empower your business strategy with our comprehensive report on the organic acid market@ https://www.futuremarketinsights.com/reports/global-organic-acids-market

[shubhampawrainfinium]

Harnessing Light for Life: The Promise of Biophotonics

The report on the global biophotonics market offers an in-depth analysis of its segments and sub-segments, examining trends, growth drivers, and future projections for the period of 2015 to 2023. According to the report, the global biophotonics market is expected to grow at a compound annual growth rate (CAGR) of 8.5% over the forecast period of 2023 to 2030. By 2030, the market is projected to reach USD 115 billion, driven by advancements in medical applications, diagnostics, and research technologies.

What is Biophotonics?

Biophotonics refers to the use of light-based technologies to study, diagnose, and treat biological systems. This field combines principles from photonics and biology to create tools for applications such as medical imaging, diagnostics, and therapeutic treatments. Biophotonics includes a wide range of technologies, including fluorescence, optical coherence tomography, and biosensors, among others, that enable the analysis of biological samples at the molecular level.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/879

Market Drivers and Growth Factors

Several factors are driving the growth of the biophotonics market:

Increasing Demand for Advanced Diagnostic Tools: With the rise of chronic diseases and the increasing need for early diagnosis, biophotonics plays a critical role in providing more accurate, non-invasive diagnostic solutions. Technologies such as optical imaging and Raman spectroscopy enable earlier detection of conditions like cancer and cardiovascular diseases.

Rising Healthcare Expenditure: Increased healthcare spending globally is propelling the adoption of advanced technologies, including biophotonics. Governments and private organizations are investing in research and development for more effective diagnostic and therapeutic tools.

Technological Advancements: Advances in photonics, such as improved lasers, detectors, and sensors, are opening new possibilities in biophotonics. Developments in minimally invasive surgical tools, biosensors, and optical coherence tomography are particularly prominent.

Aging Population: The global aging population is increasing the demand for healthcare services, including advanced diagnostic tools. Biophotonics is critical for improving the detection and treatment of age-related diseases like Alzheimer’s, arthritis, and various forms of cancer.

Regional Analysis

North America: North America holds a significant share of the global biophotonics market, driven by the presence of leading healthcare providers, research institutions, and a high rate of adoption of cutting-edge medical technologies. The U.S. is the dominant market in this region, with high demand for biophotonics in medical diagnostics, imaging, and therapy.

Europe: Europe also represents a substantial market share, particularly in countries like Germany, the UK, and France. The region benefits from strong healthcare systems, significant government investments in healthcare infrastructure, and advancements in biophotonics research.

Asia-Pacific: The Asia-Pacific region is expected to experience the highest growth rate during the forecast period. Countries like China, India, and Japan are investing heavily in healthcare infrastructure, with a rising demand for advanced medical technologies. The region's expanding biotechnology and pharmaceutical industries also drive the need for biophotonics in research and development.

Rest of the World: The Middle East, Latin America, and Africa are gradually expanding their adoption of biophotonics, largely driven by improvements in healthcare access, governmental health initiatives, and growing biomedical research activities.

Competitive Landscape

The biophotonics market is competitive, with key players focusing on technological advancements, strategic partnerships, and expanding their product offerings:

Hamamatsu Photonics K.K.: A leading provider of photonic solutions, Hamamatsu specializes in advanced optical sensors and imaging equipment, which are widely used in biophotonics applications for medical diagnostics.

Olympus Corporation: Olympus is a significant player in the biophotonics market, offering a range of advanced optical imaging systems used for medical research, diagnostics, and surgeries.

Carl Zeiss AG: Zeiss provides optical systems for medical applications, including biophotonics solutions for high-resolution imaging and diagnostics, playing a major role in the market’s growth.

Thermo Fisher Scientific: A global leader in biotechnology and life sciences, Thermo Fisher manufactures biophotonics tools used in molecular and cellular analysis, as well as diagnostic technologies.

Siemens Healthineers: Siemens Healthineers develops advanced imaging technologies that incorporate biophotonics, offering cutting-edge solutions for medical diagnostics and imaging applications.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-biophotonics-market

Challenges and Opportunities

Challenges:

High Initial Investment: The cost of biophotonics technologies can be prohibitively high, making it difficult for small and medium-sized healthcare providers in emerging markets to adopt these technologies.

Regulatory Hurdles: The biophotonics industry is highly regulated, especially in healthcare applications. Regulatory approvals for new technologies can be time-consuming and costly.

Technological Complexity: While biophotonics offers numerous advantages, the complexity of the technology can make it difficult for end-users to fully implement and optimize these solutions without proper training and support.

Opportunities:

Minimally Invasive Techniques: Biophotonics technologies such as endoscopy and optical coherence tomography offer significant opportunities in minimally invasive surgeries, improving patient outcomes and reducing recovery times.

Personalized Medicine: The growing field of personalized medicine presents a key opportunity for biophotonics, as technologies like gene expression profiling and molecular imaging allow for targeted treatments based on individual patient characteristics.

Emerging Markets: Expanding healthcare infrastructure in emerging markets, particularly in Asia-Pacific, Latin America, and the Middle East, creates significant growth opportunities for biophotonics providers to enter new regions.

Conclusion

The global biophotonics market is poised for significant growth, with a projected CAGR of 8.5% through 2030. The increasing demand for advanced medical diagnostics, coupled with technological advancements, is expected to drive this growth. The market's future is shaped by innovations in imaging, diagnostics, and therapy, which will continue to benefit from investments in research, healthcare infrastructure, and aging populations worldwide. By 2030, the global biophotonics market is projected to reach USD 115 billion, representing the critical role that biophotonics will play in shaping the future of healthcare.

[news365timesindia]

[ad_1] External Affairs Minister S Jaishankar on Wednesday underscored the deepening relationship between India and the Philippines, rooted in “shared democratic values, pluralistic ethos, and economic commonalities.” Speaking at an event celebrating 75 years of diplomatic relations between the two nations, Jaishankar highlighted the importance of their commitment to upholding international law and norms. Marking this milestone, Jaishankar shared a post on X, saying, “Glad to attend the celebrations marking 75 years of India-Philippines Diplomatic ties.” Glad to attend the celebrations marking 75 years of India-Philippines Diplomatic ties. The logo for the occasion captures our special relations rooted in democratic values, pluralistic ethos and economic commonalities. Our convergences and shared interest in the Indo-Pacific… pic.twitter.com/FZVormOWDW — Dr. S. Jaishankar (@DrSJaishankar) November 13, 2024 “Our ties are rooted in democratic values, pluralistic ethos and economic commonalities,” Jaishankar said, adding that recent years have seen substantial growth in bilateral trade and investments, especially in sectors such as IT, pharmaceuticals, infrastructure, and FMCG. The minister also pointed to enhanced defence and security cooperation, driven by shared interests and converging strategies in the Indo-Pacific region. “Our relationship has also been a natural beneficiary of India’s Act East policy. As we engage ever more closely with the ASEAN and nations beyond, let me recognise that the Philippines is the country coordinator for India,” he noted. Formal diplomatic relations between India and the Philippines were established on November 26, 1949, soon after both nations gained independence. The two countries enjoy friendly relations based on shared values, including a commitment to democracy, rule of law, an independent judiciary, and a free press, according to the Ministry of External Affairs. As Jaishankar noted, this anniversary is both a celebration of past achievements and a promise of even closer ties ahead. Click here for Latest Fact Checked News On NewsMobile WhatsApp Channel For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram [ad_2] Source link

[news365times]

[ad_1] External Affairs Minister S Jaishankar on Wednesday underscored the deepening relationship between India and the Philippines, rooted in “shared democratic values, pluralistic ethos, and economic commonalities.” Speaking at an event celebrating 75 years of diplomatic relations between the two nations, Jaishankar highlighted the importance of their commitment to upholding international law and norms. Marking this milestone, Jaishankar shared a post on X, saying, “Glad to attend the celebrations marking 75 years of India-Philippines Diplomatic ties.” Glad to attend the celebrations marking 75 years of India-Philippines Diplomatic ties. The logo for the occasion captures our special relations rooted in democratic values, pluralistic ethos and economic commonalities. Our convergences and shared interest in the Indo-Pacific… pic.twitter.com/FZVormOWDW — Dr. S. Jaishankar (@DrSJaishankar) November 13, 2024 “Our ties are rooted in democratic values, pluralistic ethos and economic commonalities,” Jaishankar said, adding that recent years have seen substantial growth in bilateral trade and investments, especially in sectors such as IT, pharmaceuticals, infrastructure, and FMCG. The minister also pointed to enhanced defence and security cooperation, driven by shared interests and converging strategies in the Indo-Pacific region. “Our relationship has also been a natural beneficiary of India’s Act East policy. As we engage ever more closely with the ASEAN and nations beyond, let me recognise that the Philippines is the country coordinator for India,” he noted. Formal diplomatic relations between India and the Philippines were established on November 26, 1949, soon after both nations gained independence. The two countries enjoy friendly relations based on shared values, including a commitment to democracy, rule of law, an independent judiciary, and a free press, according to the Ministry of External Affairs. As Jaishankar noted, this anniversary is both a celebration of past achievements and a promise of even closer ties ahead. Click here for Latest Fact Checked News On NewsMobile WhatsApp Channel For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram [ad_2] Source link

[sudheervanguri]

Macleods Pharmaceuticals Walk-in Drive Macleods Pharmaceuticals, a leading name in the pharmaceutical industry, is conducting a walk-in drive for multiple roles across Production, Quality Assurance (QA), Quality Control (QC), Engineering, and Stores departments. This hiring event, taking place in Rangpo, East Sikkim, offers an excellent opportunity for candidates with relevant qualifications and experience to work with one of India's premier pharmaceutical companies. Here’s everything you need to know about the job roles, requirements, and application details. Pharma Jobs in Rangpo, East Sikkim Walk-in Drive Details Date: November 17, 2024 Time: 09:00 AM onwards Venue: Eco Paradise Resort, NH 10, Mining, Near Rangpo, East Sikkim - 737132 Contact Numbers: 7477714922, 8768996504, 9046006953 Candidates are encouraged to bring their updated CV, a detailed salary structure (CTC breakdown), and a government-issued ID for verification. Available Positions at Macleods Pharmaceuticals 1. Production Department (DPI & Tablet OSD) Roles: Sr. Officer, Officer, TA/Operator Responsibilities: Candidates will manage various stages of production, including DPI, Granulation, Compression, Coating, and Packing for Oral Solid Dosage (OSD) forms. Qualifications: B.Pharm, M.Pharm, ITI, or Diploma in Engineering Experience: 2–8 years in DPI washing, sterilization, compounding, and sealing activities 2. Production (Liquid Injection & Oral Liquid) Roles: Executive, Officer Responsibilities: Oversee production processes for injectable and oral liquid forms, ensuring compliance with IPQA, validation, and documentation standards. Qualifications: M.Pharm, B.Pharm, ITI, Diploma in Engineering Experience: 2–8 years in Liquid Injection sterile environments 3. Quality Assurance (QA) and Quality Control (QC) Roles: Officer, Executive Responsibilities: Ensure product quality, manage documentation, and maintain GLP standards. This includes handling raw materials, finished goods, and stability studies. Qualifications: M.Sc., B.Pharm, M.Pharm Experience: 2–8 years in QA/QC activities related to pharmaceutical products 4. Engineering Services Roles: Officer, Executive Responsibilities: Handle electrical, mechanical, HVAC, and utility services for optimal plant operations. Qualifications: Diploma in Engineering, ITI, or B.Tech Experience: 4–10 years in mechanical and electrical engineering processes 5. Stores Department Roles: Executive, Officer, TA Responsibilities: Manage receipt and dispersal of raw materials, inventory control, packing, and dispensing activities. Qualifications: B.Sc., B.Com, D.Pharm Experience: 2–8 years in store management and material handling Qualification & Skills Required Candidates should possess the following: Educational Background: Relevant qualifications such as B.Pharm, M.Pharm, D.Pharm, ITI, Diploma in Engineering, B.Tech, or B.Sc. Experience: 2–10 years in the respective roles with hands-on experience in pharmaceutical processes, manufacturing, engineering maintenance, or store management. Technical Skills: Familiarity with GMP, GLP, IPQA standards, and documentation practices. Interpersonal Skills: Strong teamwork, communication, and compliance with quality and safety standards. [caption id="attachment_56144" align="alignnone" width="300"] MACLEODS Walk-in Drive for Production, QA, and Stores[/caption] How to Apply for Macleods Pharmaceuticals Walk-in Drive To streamline the registration process, candidates are encouraged to register online through Macleods’ official link. This ensures quicker processing and helps the recruitment team manage applications more effectively. Please follow this link (preferably in Google Chrome) for registration: Macleods Registration. Note: Remember to bring the following documents: Updated CV Salary structure with CTC breakdown Aadhar card or any government-issued ID